Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

EyePoint, Inc. - Common Stock (NQ:EYPT)

3.870 -0.120 (-3.01%)
Streaming Delayed Price Updated: 3:55 PM EDT, Sep 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,680,175
Open 3.950
Bid (Size) 3.860 (3,000)
Ask (Size) 3.870 (3,300)
Prev. Close 3.990
Today's Range 3.774 - 4.060
52wk Range 3.415 - 19.11
Shares Outstanding 34,984,044
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT
From Pomerantz LLP
Via GlobeNewswire
News headline image
Investigation Launched Into EyePoint, Inc., EYPT Investors are Encouraged to Contact KTMC Law Firm
RADNOR, PA - September 9, 2026 (NEWMEDIAWIRE) - Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm, is investigating potential violations of the... 
Via NewMediaWire

Performance

YTD
-77.9%
-77.9%
1 Month
-29.3%
-29.3%
3 Month
-71.5%
-71.5%
6 Month
-71.9%
-71.9%
1 Year
-71.6%
-71.6%

More News

Read More
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTIGATION ALERT: Investigation Launched Into EyePoint, Inc. (EYPT), Investors are Encouraged to Contact Kessler Topaz Meltzer & Check, LLP
Via NewMediaWire
EyePoint (NASDAQ:EYPT) Rallies Despite Wider Q2 Loss as Phase 3 Data Nears ↗
Via Chartmill
News headline image
EYEPOINT STOCKHOLDER ALERT: Bragar Eagel & Squire, P.C. is Investigating EyePoint, Inc. on Behalf of EyePoint Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
EYPT ALERT: Investigation Launched Into EyePoint, Inc., Investors are Encouraged to Contact KTMC Law Firm
Via NewMediaWire
News headline image
EYPT SHAREHOLDER ALERT: EyePoint Pharmaceuticals Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
From Kirby McInerney LLP
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT
From Pomerantz LLP
Via GlobeNewswire
News headline image
Kessler Topaz Meltzer & Check, LLP Encourages EyePoint, Inc. (NASDAQ: EYPT) Investors to Contact the Firm
Via NewMediaWire
News headline image
NASDAQ: EYPT: Kessler Topaz Meltzer & Check, LLP Launches Investigation Into EyePoint, Inc.
Via NewMediaWire
News headline image
EYPT Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages EYPT Investors With Losses to Contact the Firm
Via NewMediaWire
News headline image
EYPT Investors Have Opportunity to Join EyePoint, Inc. Fraud Investigation with SBS Law
From Schall, Brown & Schwartz LLP
Via Business Wire
News headline image
NASDAQ: EYPT Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages EyePoint, Inc. (NASDAQ: EYPT) Investors to Contact the Firm
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of EyePoint, Inc. - EYPT
From Pomerantz LLP
Via GlobeNewswire
News headline image
EYPT Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into EyePoint Pharmaceuticals (EYPT)
From Levi & Korsinsky, LLP
Via Business Wire
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Via Chartmill
News headline image
EyePoint’s DURAVYU Misses Primary Endpoint in Phase III Wet AMD Trial ↗
Via MarketBeat
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
These stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
Will SpaceX Stock Double Anytime Soon? No -- but These 3 Stocks Could ↗
Via The Motley Fool
News headline image
EyePoint Pharmaceuticals Eyes Transformative 2026 as DURAVYU Phase 3 Data Nears ↗
Via MarketBeat
News headline image
Alumis Stock Has Soared 400%. Cormorant Bought Another $8 Million Last Quarter ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why This Fund Just Made a $55 Million Bet on Dianthus Amid a 350% Stock Rally ↗
Via The Motley Fool

Frequently Asked Questions

Is EyePoint, Inc. - Common Stock publicly traded?
Yes, EyePoint, Inc. - Common Stock is publicly traded.
What exchange does EyePoint, Inc. - Common Stock trade on?
EyePoint, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for EyePoint, Inc. - Common Stock?
The ticker symbol for EyePoint, Inc. - Common Stock is EYPT on the Nasdaq Stock Market
What is the current price of EyePoint, Inc. - Common Stock?
The current price of EyePoint, Inc. - Common Stock is 3.870
When was EyePoint, Inc. - Common Stock last traded?
The last trade of EyePoint, Inc. - Common Stock was at 09/18/26 03:55 PM ET
What is the market capitalization of EyePoint, Inc. - Common Stock?
The market capitalization of EyePoint, Inc. - Common Stock is 135.39M
How many shares of EyePoint, Inc. - Common Stock are outstanding?
EyePoint, Inc. - Common Stock has 135M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.